{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:28:21Z","timestamp":1781760501782,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009240","name":"Sveriges Kommuner och Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH Library","doi-asserted-by":"publisher","award":["CA 193249"],"award-info":[{"award-number":["CA 193249"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH Library","doi-asserted-by":"publisher","award":["CA 140933"],"award-info":[{"award-number":["CA 140933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ygyno.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T17:16:08Z","timestamp":1724346968000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quality of life and survivorship in patients with low-grade ovarian cancer"],"prefix":"10.1016","volume":"190","author":[{"given":"Mackenzie","family":"Lemieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goodheart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Dahmoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Penedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve W.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Lutgendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premal H.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2024.08.010_bb0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.ygyno.2024.08.010_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1016\/j.ygyno.2024.08.010_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cncr.25588","article-title":"Molecular typing of epithelial ovarian carcinomas using inflammatory markers","volume":"117","author":"Ali-Fehmi","year":"2011","journal-title":"Cancer"},{"issue":"32","key":"10.1016\/j.ygyno.2024.08.010_bb0025","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.20.01164","article-title":"MILO\/ENGOT-ov11: Binimetinib versus Physician's choice chemotherapy in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum","volume":"38","author":"Monk","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.08.010_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-020-00971-6","article-title":"High-throughput approaches for precision medicine in high-grade serous ovarian cancer","volume":"13","author":"Govindarajan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2024.08.010_bb0035","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1200\/JCO.2005.08.147","article-title":"Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a gynecologic oncology group study","volume":"23","author":"Wenzel","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"15_suppl","key":"10.1016\/j.ygyno.2024.08.010_bb0040","doi-asserted-by":"crossref","first-page":"e21570","DOI":"10.1200\/JCO.2016.34.15_suppl.e21570","article-title":"Quality of life among long-term ovarian cancer survivors","volume":"34","author":"Wenzel","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2011.07.028","article-title":"The effect of sleep disturbance on quality of life in women with ovarian cancer","volume":"123","author":"Sandadi","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"17","key":"10.1016\/j.ygyno.2024.08.010_bb0050","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/cncr.28188","article-title":"Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis","volume":"119","author":"Clevenger","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.08.010_bb0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2013.09.025","article-title":"Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients","volume":"131","author":"Lutgendorf","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2024.08.010_bb0060","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1200\/JCO.2011.39.4411","article-title":"Social influences on clinical outcomes of patients with ovarian cancer","volume":"30","author":"Lutgendorf","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.08.010_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"29","key":"10.1016\/j.ygyno.2024.08.010_bb0070","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2007.14.1978","article-title":"Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients","volume":"26","author":"Lutgendorf","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.08.010_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/gyno.1997.4726","article-title":"Serum evaluation of interleukin 6 in ovarian cancer patients","volume":"66","author":"Tempfer","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cncr.21147","article-title":"Psychosocial factors and interleukin-6 among women with advanced ovarian cancer","volume":"104","author":"Costanzo","year":"2005","journal-title":"Cancer"},{"issue":"Suppl(0)","key":"10.1016\/j.ygyno.2024.08.010_bb0085","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.bbi.2012.07.022","article-title":"Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability","volume":"30","author":"Schrepf","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.ygyno.2024.08.010_bb0090","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jama.1992.03480090092034","article-title":"The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis","volume":"267","author":"Chrousos","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2024.08.010_bb0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psyneuen.2015.01.010","article-title":"Diurnal cortisol and survival in epithelial ovarian cancer","volume":"53","author":"Schrepf","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.ygyno.2024.08.010_bb0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.JGP.0000201816.26786.5b","article-title":"Design decisions to optimize reliability of daytime cortisol slopes in an older population","volume":"14","author":"Kraemer","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.ygyno.2024.08.010_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Measur."},{"issue":"1","key":"10.1016\/j.ygyno.2024.08.010_bb0110","first-page":"37","article-title":"The provisions of social relationships and adaptation to stress","volume":"1","author":"Cutrona","year":"1987","journal-title":"Adv. Personal Relationships"},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.ygyno.2024.08.010_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of Cancer therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.08.010_bb0125","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","article-title":"Reliability and validity of the functional assessment of cancer therapy-ovarian","volume":"19","author":"Basen-Engquist","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0163278705275341","article-title":"General population and cancer patient norms for the functional assessment of Cancer therapy-general (FACT-G)","volume":"28","author":"Brucker","year":"2005","journal-title":"Eval. Health Prof."},{"key":"10.1016\/j.ygyno.2024.08.010_bb0135","series-title":"Manual Profile of Mood States","author":"McNair","year":"1971"},{"issue":"4","key":"10.1016\/j.ygyno.2024.08.010_bb0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pon.564","article-title":"A POMS short form for cancer patients: psychometric and structural evaluation","volume":"11","author":"Baker","year":"2002","journal-title":"Psycho-Oncology"},{"issue":"4","key":"10.1016\/j.ygyno.2024.08.010_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.ygyno.2024.08.010_bb0150","series-title":"The social psychology of health: Claremont Symposium on Applied Social Psychology","article-title":"Perceived stress in a probability sample of the United States","author":"Cohen","year":"1988"},{"issue":"3","key":"10.1016\/j.ygyno.2024.08.010_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000118611","article-title":"Salivary cortisol in psychobiological research: an overview","volume":"22","author":"Kirschbaum","year":"1989","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.ygyno.2024.08.010_bb0160","first-page":"79","article-title":"The cortisol awakening response - normal values and confounds","volume":"2","author":"W\u00fcst","year":"2000","journal-title":"Noise Health"},{"issue":"12","key":"10.1016\/j.ygyno.2024.08.010_bb0165","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnci\/92.12.994","article-title":"Diurnal cortisol rhythm as a predictor of breast cancer survival","volume":"92","author":"Sephton","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0170","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cam4.4976","article-title":"Mental health disorders among ovarian cancer survivors in a population-based cohort","volume":"12","author":"Hu","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ygyno.2024.08.010_bb0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.sleep.2019.10.008","article-title":"Cancer-related problems, sleep quality, and sleep disturbance among long-term cancer survivors at 9-years post diagnosis","volume":"65","author":"Strollo","year":"2020","journal-title":"Sleep Med."},{"issue":"5","key":"10.1016\/j.ygyno.2024.08.010_bb0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/ijgc-2022-003404","article-title":"Sleep and gynecological cancer outcomes: opportunities to improve quality of life and survival","volume":"32","author":"Zhao","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2024.08.010_bb0185","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0190","first-page":"155","article-title":"Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93)","volume":"7","author":"Schink","year":"2001","journal-title":"Cancer J."},{"issue":"22","key":"10.1016\/j.ygyno.2024.08.010_bb0195","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1200\/JCO.2004.08.080","article-title":"Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study","volume":"22","author":"Bezjak","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.08.010_bb0200","series-title":"SGO Annual Meeting of Women\u2019s Cancer, San Diego, CA","article-title":"Voices of women with low-grade serous ovarian cancer: Results from a multinational survey, in Poster #2269","author":"Sun","year":"2024"},{"issue":"2","key":"10.1016\/j.ygyno.2024.08.010_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1078-0432.CCR-05-1698","article-title":"Stress hormone-mediated invasion of ovarian cancer cells","volume":"12","author":"Sood","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.ygyno.2024.08.010_bb0210","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2005.02.0081","article-title":"Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer","volume":"24","author":"Bardwell","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.ygyno.2024.08.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016620","article-title":"Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.ygyno.2024.08.010_bb0220","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.71.0632","article-title":"Hormonal maintenance therapy for women with low-grade serous cancer of the ovary or peritoneum","volume":"35","author":"Gershenson","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T02:06:07Z","timestamp":1730945167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824010643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":44,"alternative-id":["S0090825824010643"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.08.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life and survivorship in patients with low-grade ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}